Betsy Foxman, Ph.D. Molecular epidemiology of infectious disease. bfoxman@umich.edu (734) 764-5487
Molecular epidemiology of bacterial pathogens.
(734) 647-2407
Dr. Mody is Amanda Sanford Hickey Professor of Internal Medicine; Associate Division Chief, Geriatric & Palliative Care Medicine; Director, UM Pepper Center Pilot & Exploratory Studies Core; Associate Director, Clinical and Translational Research, Geriatrics Center; Associate Director for Clinical Programs at the VA Ann Arbor GRECC. She has an active translational research laboratory to define the clinical and molecular epidemiology of antimicrobial resistant pathogens and developing measures to prevent them.
Alexander H. Rickard, Ph.D., M.Sc., B.Sc.
Assistant Professor, Department of Epidemiology
Alex Rickard focuses on interspecies bacterial interactions and relevance to human health Biofilm development in freshwater, oral and medically relevant environments Interaction of the human microbiome with environmental microorganisms
Betsy Salzmaneahaak@umich.edu
Anna Cronenwettweaverd@umich.edu(734) 764-5462
Carl P. Simon is Professor of Mathematics, Economics, and Public Policy. His research interests center around mathematical models which involve natural dynamics or motion over time. He has applied dynamic modeling to the movements of an economy over time, the spread of AIDS, and the evolution of biological and economic systems. Carl has also conducted research on how political office holders manipulate economic parameters to achieve their goals. In May 1999, the University established the Center for the Study of Complex Systems and appointed Carl director. He is co-author of a textbook Mathematics for Economists. Carl teaches calculus and operations research at the Ford School. He received his Ph.D. from Northwestern University.
Hasan Abu-Amara (PhD)
Deesha Bhaumik (MPH)
Freida Blostein (PhD)
Elyse Davis (MPH)
Jennifer McLenon (MPH)
Evan Snitkin is an Assistant Professor of Microbiology & Immunology. His lab is interested in the application of genomics to understand the epidemiology and evolution of antibiotic resistant bacterial pathogens. The paradigm in the lab involves close collaboration with experts in healthcare epidemiology, clinical microbiology and basic microbiology to design genomics-empowered studies that maximize clinical significance and evolutionary insights.